Observation on effect of danxiaoling in supplementary treatment of intrahepatic cholestasis in pregnancy.
- Author:
Dian-yun SHI
1
;
Hua CHEN
;
Mei XIAO
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Alanine Transaminase; blood; Aspartate Aminotransferases; blood; Cholestasis, Intrahepatic; blood; drug therapy; Drugs, Chinese Herbal; therapeutic use; Female; Glycocholic Acid; blood; Humans; Phytotherapy; Pregnancy; Pregnancy Complications; blood; drug therapy
- From: Chinese Journal of Integrated Traditional and Western Medicine 2002;22(2):116-118
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the curative effect of Danxiaoling Pill (DXLP), a Chinese herbal preparation, in treating intrahepatic cholestasis in pregnancy (ICP).
METHODSFifty-eight cases of ICP were divided randomly into two groups and treated by DXLP and Composite Yiganling as control respectively with the other identical conventional treatment. The changes of clinical symptoms, related laboratory parameters after treatment and the condition of labor were observed.
RESULTSThe total effective rate in both groups was 100%, but the markedly effective rate in the DXLP treated group was higher than that in control group (P < 0.01). Levels of blood cholyglycine acid (CGA), alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin, total cholesterol and low density lipoprotein were all decreased in both groups after treatment, but DXL showed a better efficacy in decreasing CGA, ALT and AST than that of Yiganling. Moreover, the amniotic fluid meconium contaminated rate, premature delivery occurrence in the DXLP group were lower than those in the control group, while the weight of newborn baby was higher in the former than in the latter.
CONCLUSIONDXLP could effectively lower the serum bile acid and improve liver function in treating ICP.
